The Scientific Advisory Board acts as a consultative and advisory body on medical and clinical matters reporting to Opaldia’s Board of Directors. The SAB is responsible for clinical governance and reporting on clinical aspects of the company’s corporate strategy. It also considers applications for Practising Privileges for consultants and specialists to work at Opaldia. The Scientific Advisory Board has representatives from each specialty working within the company and is chaired on medical matters by a senior consultant, currently Professor Karol Sikora. Members serve for a two-year period of office.
Professor Karol Sikora - SAB Chairman
Professor Karol Sikora is Professor of Cancer Medicine and Honorary Consultant Oncologist at Imperial College School of Medicine, Hammersmith Hospital, London where he was Clinical Director of Cancer Services for 12 years. He is Medical Director of CancerPartnersUK which is creating the largest independent sector cancer network outside the NHS. He is also Scientific Director of Medical Solutions PLC, Britain’s leading cancer diagnostic company. He has been appointed Dean of Britain’s first independent Medical School at the Universities of Brunel and Buckingham.
Mr Paul Apps
Mr Paul Apps is the Operations Director at The London Clinic; the UK’s largest private charitable hospital. The Clinic focuses on complex medicine and surgery, in particular cancer services.
Professor John Burn
Professor Burn is Honorary Consultant Clinical Geneticist at Newcastle Hospitals NHS Trust. He is also Medical Director for the Institute of Human Genetics, Executive Director of the Life Knowledge Park, Honorary Director for Cancer Research (UK) Clinical Cancer Genetics Network, University Public Orator and Member of the UK Human Genetics Commission.
Dr Peter Fairclough
Dr peter Fairclough is a Consultant Gatroenterologist and Endoscopist and is a Consultant at Barts and the London NHS Trust.
Mr Gerald Gui
Mr Gerald Gui is a Consultant Breast Surgeon at the Royal Marsden Hospital. Mr Gui heads the Marsden’s Breast Screening programme. His research interests are in the tumour biology of breast cancer metastases and the intraductal approach to breast diagnosis. He is also the London representative of the Association of Breast Surgery Honorary Senior Lecturer to the Institute of Cancer Research, London.
Ms Amanda Hallums
Ms Amanda Hallums is the Director of Clinical and Nursing Services at The London Clinic; London’s largest private hospital which focuses on complex medicine and surgery including cancer services.
Professor Ian Jacobs
Professor Ian Jacobs is a Gynaecologist and Oncologist and directs a proteomics, genomics and clinical trials research group at UCL focused on cancer diagnosis, screening and prevention. He is Vice Dean UCL Faculty of Biomedicine, Director of the UCLH/UCL Comprehensive Biomedical Centre and Director of the UCL Institute for Women's Health.
Professor Roger Kirby
Professor Roger Kirby qualified from the University of Cambridge in 1975 with a distinction in surgery. He became a consultant at St Bartholomew’s Hospital in 1986 and nine years later moved to St George’s Hospital where he was awarded a personal chair in Urology and also became Director of Post-Graduate education. He is now a visiting Professor at St George’s Hospital and is a founding Director of the Prostate Centre in Central London.
Dr Maurice Slevin
Dr Maurice Slevin MD FRCP is Senior Consultant Medical Oncologist at St Bartholomew’s Hospital, London, specialising in the treatment of breast, gastrointestinal and gynaecological cancers. He has been interested in the emotional and psychological aspects of cancer for many years and is Chairman of the national cancer information and support charity, Cancerbackup. Dr Slevin is a founding Director of The London Oncology Clinic.
Dr Laura Van't Veer
Dr Laura van't Veer has a 20-year track record in molecular oncology research (more than 80 papers published in peer-reviewed journals) and has developed Agendia's MammaPrint® gene expression profiling service. Dr van't Veer was for 10 years head of the Family Cancer Clinic at the Netherlands Cancer Institute (NKI). She is presently head of the clinic's DNA-diagnostic laboratory and she is also a staff member at the NKI's department of Molecular Pathology. She is the COO and a co-founder of Agendia.